WHO ICTRP trial
A Single Ascending Dose Study to Assess the Safety, Tolerability, and…
ChiCTR1800016198 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1800016198 |
|---|---|
| Public title | A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Mecripyrine Hydrochloride Tablet |
| Scientific title | A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Mecripyrine Hydrochloride Tablet |
| Primary sponsor | West China Hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Alzheimer's disease, AD |
| Interventions | Dose Improved by Fibonacci method, dose group is: 5 mg (6 cases), 10 mg (12 cases), 20 mg (12 cases) and 40 mg (12 cases), 80 mg (12 cases), 120 mg (8 cases), 180 mg (8 cases), 240 (6 cases) 8 mg dose group, All of the subjects cases are 76… |
| Registration date | May 18, 2018 |
| Target size | Dose Improved by Fibonacci method, dose group is: 5 mg (6 cases), 10 mg (12… |
| Secondary IDs | 2016L07059 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: